{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:10:48Z","timestamp":1764828648801},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00345-018-2536-8","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T12:44:23Z","timestamp":1540471463000},"page":"1347-1352","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study"],"prefix":"10.1007","volume":"37","author":[{"given":"Ahmed S.","family":"Safwat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Hasanain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Shahat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"AbdelRazek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Orabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir K.","family":"Abdul Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany","family":"Nafee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Bakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"2536_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMcp1503950","volume":"374","author":"AJ Schaeffer","year":"2016","unstructured":"Schaeffer AJ, Nicolle LE (2016) Urinary tract infections in older men. N Engl J Med 374:562\u2013571","journal-title":"N Engl J Med"},{"key":"2536_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC et al (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474\u2013479","journal-title":"J Urol"},{"key":"2536_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/tre.8","volume":"12","author":"M Harper","year":"2007","unstructured":"Harper M, Fowlis G (2007) Management of urinary tract infections in men. Trends Urol Gynecol Sex Health 12:30\u201335","journal-title":"Trends Urol Gynecol Sex Health"},{"key":"2536_CR4","first-page":"290","volume":"21","author":"G Pourmand","year":"2010","unstructured":"Pourmand G, Abedi AR, Karami AA et al (2010) Urinary infection before and after prostatectomy. Saudi J Kidney Dis Transpl 21:290\u2013294","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2536_CR5","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"2536_CR6","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1210\/jcem-57-6-1308","volume":"57","author":"AK Bhalla","year":"1983","unstructured":"Bhalla AK, Amento EP, Clemens TL et al (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57:1308\u20131310","journal-title":"J Clin Endocrinol Metab"},{"key":"2536_CR7","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1128\/IAI.00353-08","volume":"76","author":"JH White","year":"2008","unstructured":"White JH (2008) Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun 76:3837\u20133843","journal-title":"Infect Immun"},{"key":"2536_CR8","doi-asserted-by":"publisher","first-page":"e1099","DOI":"10.1016\/j.ijid.2010.09.002","volume":"14","author":"A Juzeniene","year":"2010","unstructured":"Juzeniene A, Ma LW, Kwitniewski M et al (2010) The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D. Int J Infect Dis 14:e1099\u2013e1105","journal-title":"Int J Infect Dis"},{"key":"2536_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/MAJ.0000000000000360","volume":"349","author":"MD Kearns","year":"2015","unstructured":"Kearns MD, Alvarez JA, Seidel N et al (2015) Impact of vitamin D on infectious disease. Am J Med Sci 349:245\u2013262","journal-title":"Am J Med Sci"},{"key":"2536_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/jac\/dkq465","volume":"66","author":"WE Starre van der","year":"2011","unstructured":"van der Starre WE, van Nieuwkoop C, Paltansing S et al (2011) Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother 66:650\u2013656","journal-title":"J Antimicrob Chemother"},{"key":"2536_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.7326\/0003-4819-110-2-138","volume":"110","author":"BA Lipsky","year":"1989","unstructured":"Lipsky BA (1989) Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med 110:138\u2013150","journal-title":"Ann Intern Med"},{"key":"2536_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.1464-410x.1999.00164.x","volume":"84","author":"P Ulleryd","year":"1999","unstructured":"Ulleryd P, Zackrisson B, Aus G et al (1999) Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography. BJU Int 84:470\u2013474","journal-title":"BJU Int"},{"key":"2536_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cellimm.2005.04.013","volume":"233","author":"L Adorini","year":"2005","unstructured":"Adorini L (2005) Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 233:115\u2013124","journal-title":"Cell Immunol"},{"key":"2536_CR14","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1210\/en.2006-0946","volume":"147","author":"AW Norman","year":"2006","unstructured":"Norman AW (2006) Vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147:5542\u20135548","journal-title":"Endocrinology"},{"key":"2536_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nm1407","volume":"12","author":"M Chromek","year":"2006","unstructured":"Chromek M, Slamov\u00e1 Z, Bergman P et al (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636\u2013641","journal-title":"Nat Med"},{"key":"2536_CR16","doi-asserted-by":"publisher","first-page":"e15580","DOI":"10.1371\/journal.pone.0015580","volume":"5","author":"O Hertting","year":"2010","unstructured":"Hertting O, Holm \u00c5, L\u00fcthje P et al (2010) Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder. PLoS One 5:e15580","journal-title":"PLoS One"},{"key":"2536_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/MNH.0b013e3282ff64a3","volume":"17","author":"DD Bikle","year":"2008","unstructured":"Bikle DD (2008) Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 17:348\u2013352","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2536_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijmyco.2012.11.001","volume":"2","author":"D Eklund","year":"2013","unstructured":"Eklund D, Persson HL, Larsson M et al (2013) Vitamin D enhances IL-1\u03b2 secretion and restricts growth of Mycobacterium tuberculosis in macrophages from TB patients. Int J Mycobacteriol 2:18\u201325","journal-title":"Int J Mycobacteriol"},{"key":"2536_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1096\/fj.04-3284com","volume":"19","author":"AF Gombart","year":"2005","unstructured":"Gombart AF, Borregaard N, Koeffler HP (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19:1067\u20131077","journal-title":"FASEB J"},{"key":"2536_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/23744235.2016.1201853","volume":"48","author":"R Jorde","year":"2016","unstructured":"Jorde R, Sollid ST, Svartberg J et al (2016) Prevention of urinary tract infections with vitamin D supplementation 20,000 IU per week for five years results from an RCT including 511 subjects. Infect Dis (Lond) 48:823\u2013828","journal-title":"Infect Dis (Lond)"},{"key":"2536_CR21","first-page":"6820","volume":"20","author":"G Espinosa","year":"2013","unstructured":"Espinosa G, Esposito R, Kazzazi A et al (2013) Vitamin D and benign prostatic hyperplasia\u2014a review. Can J Urol 20:6820\u20136825","journal-title":"Can J Urol"},{"key":"2536_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1749-6632.2009.05299.x","volume":"1193","author":"L Adorini","year":"2010","unstructured":"Adorini L, Penna G, Fibbi B et al (2010) Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia. Ann NY Acad Sci 1193:146\u2013152","journal-title":"Ann NY Acad Sci"},{"key":"2536_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/aje\/kwm389","volume":"167","author":"AR Kristal","year":"2008","unstructured":"Kristal AR, Arnold KB, Schenk JM et al (2008) Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 167:925\u2013934","journal-title":"Am J Epidemiol"},{"key":"2536_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2005.08.014","volume":"49","author":"E Colli","year":"2006","unstructured":"Colli E, Rigatti P, Montorsi F et al (2006) BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. Eur Urol 49:82\u201386","journal-title":"Eur Urol"},{"key":"2536_CR25","first-page":"805","volume":"54","author":"DM Peehl","year":"1994","unstructured":"Peehl DM, Skowronski RJ, Leung GK et al (1994) Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54:805\u2013810","journal-title":"Cancer Res"},{"key":"2536_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/pros.20251","volume":"64","author":"S Murthy","year":"2005","unstructured":"Murthy S, Agoulnik IU, Weigel NL (2005) Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Prostate 64:362\u2013372","journal-title":"Prostate"},{"key":"2536_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jsbmb.2005.11.004","volume":"98","author":"SW Yee","year":"2006","unstructured":"Yee SW, Campbell MJ, Simons C (2006) Inhibition of vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells. J Steroid Biochem Mol Biol 98:228\u2013235","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2536_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/pros.20896","volume":"69","author":"G Penna","year":"2009","unstructured":"Penna G, Fibbi B, Amuchastegui S et al (2009) The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA\/Rho kinase and NF-\u03baB pathways. Prostate 69:480\u2013493","journal-title":"Prostate"},{"key":"2536_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/AOG.0b013e3181d34806","volume":"115","author":"SS Badalian","year":"2010","unstructured":"Badalian SS, Rosenbaum PF (2010) Vitamin D and pelvic floor disorders in women: results from the National Health and Nutrition Examination Survey. Obstet Gynecol 115:795\u2013803","journal-title":"Obstet Gynecol"},{"key":"2536_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/pcan.2016.41","volume":"20","author":"AB Murphy","year":"2017","unstructured":"Murphy AB, Nyame YA, Batai K et al (2017) Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy? Prostate Cancer Prostatic Dis 20:55\u201360","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2536-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T10:52:58Z","timestamp":1576666378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2536-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2536"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2536-8","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"4 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}